Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

Irene A. Abela; Frédérique Chammartin; Alain Amstutz; Bernard Surial; Marie Ballif; Catia Marzolini; Karoline Aebi-Popp; Julia Notter; Olivier Segeral; Marcel Stoeckle; Matthias Cavassini; Enos Bernasconi; Huldrych F. Günthard; Roger D. Kouyos; Chloé Pasin

doi:10.1093/ofid/ofae502

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

Irene A. Abela, Frédérique Chammartin, Alain Amstutz, Bernard Surial, Marie Ballif, Catia Marzolini, Karoline Aebi-Popp, Julia Notter, Olivier Segeral, Marcel Stoeckle, Matthias Cavassini, Enos Bernasconi, Huldrych F. Günthard, Roger D. Kouyos, Chloé Pasin^*

^*Corresponding author for this work

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Citation (Scopus)

Abstract

The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

Original language	English
Article number	ofae502
Number of pages	4
Journal	Open Forum Infectious Diseases
Volume	11
Issue number	9
DOIs	https://doi.org/10.1093/ofid/ofae502
Publication status	Published - 9 Sept 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Keywords

Cardiovascular prevention
gender disparities
people with HIV
prescription
statin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ofid/ofae502Licence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

Abela, I. A., Chammartin, F., Amstutz, A., Surial, B., Ballif, M., Marzolini, C., Aebi-Popp, K., Notter, J., Segeral, O., Stoeckle, M., Cavassini, M., Bernasconi, E., Günthard, H. F., Kouyos, R. D., & Pasin, C. (2024). Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk. Open Forum Infectious Diseases, 11(9), Article ofae502. https://doi.org/10.1093/ofid/ofae502

@article{f378047ce2bb495795dc3f1b0acbecfb,

title = "Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk",

abstract = "The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.",

keywords = "Cardiovascular prevention, gender disparities, people with HIV, prescription, statin",

author = "Abela, {Irene A.} and Fr{\'e}d{\'e}rique Chammartin and Alain Amstutz and Bernard Surial and Marie Ballif and Catia Marzolini and Karoline Aebi-Popp and Julia Notter and Olivier Segeral and Marcel Stoeckle and Matthias Cavassini and Enos Bernasconi and G{\"u}nthard, {Huldrych F.} and Kouyos, {Roger D.} and Chlo{\'e} Pasin",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America.",

year = "2024",

month = sep,

day = "9",

doi = "10.1093/ofid/ofae502",

language = "English",

volume = "11",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "9",

}

Abela, IA, Chammartin, F, Amstutz, A, Surial, B, Ballif, M, Marzolini, C, Aebi-Popp, K, Notter, J, Segeral, O, Stoeckle, M, Cavassini, M, Bernasconi, E, Günthard, HF, Kouyos, RD & Pasin, C 2024, 'Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk', Open Forum Infectious Diseases, vol. 11, no. 9, ofae502. https://doi.org/10.1093/ofid/ofae502

TY - JOUR

T1 - Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

AU - Abela, Irene A.

AU - Chammartin, Frédérique

AU - Amstutz, Alain

AU - Surial, Bernard

AU - Ballif, Marie

AU - Marzolini, Catia

AU - Aebi-Popp, Karoline

AU - Notter, Julia

AU - Segeral, Olivier

AU - Stoeckle, Marcel

AU - Cavassini, Matthias

AU - Bernasconi, Enos

AU - Günthard, Huldrych F.

AU - Kouyos, Roger D.

AU - Pasin, Chloé

PY - 2024/9/9

Y1 - 2024/9/9

N2 - The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

AB - The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

KW - Cardiovascular prevention

KW - gender disparities

KW - people with HIV

KW - prescription

KW - statin

UR - http://www.scopus.com/inward/record.url?scp=85205017622&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofae502

DO - 10.1093/ofid/ofae502

M3 - Article (Academic Journal)

C2 - 39296341

AN - SCOPUS:85205017622

SN - 2328-8957

VL - 11

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 9

M1 - ofae502

ER -

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this